NO FEE UNLESS WE WIN
FREE CASE REVIEW

DePuy Pinnacle MDL Litigation Update

A DePuy Pinnacle Multi-district litigation status conference was held on Wednesday, April 25, 2012 at the U.S. District courthouse in Dallas, Texas.

DePuy ASR MDL Litigation Update

A DePuy ASR Multi-district litigation status conference was held on Tuesday, May 1, 2012 at the U.S. District courthouse in West Palm Beach, Florida.

Annual checks for patients with all-metal hips

On February 28, 2012, BBC News published an article regarding the growing concern surrounding metal-on-metal hip implants, particularly those with large diameter heads (36 mm or higher). Evidence against all-metal hip implants indicates that these types of devices have a higher failure rate when compared to hip implants made from other materials, such as ceramic […]

Britain Extends Monitoring for People with Metal Hips

On February 28, 2012, the New York Times published an article regarding the recent decision by British health regulators to advise patients with large metal-on-metal hip implants to undergo annual check-ups for the lifetime of the device.

How safe are metal-on-metal hip implants?

On February 28, 2012, the British Medical Journal (BMJ) published an article analyzing and discussing the risks of a popular type of medical device, the metal-on-metal hip implant.

Experts Oppose Metal-on-Metal Hips

On March 13, 2012, the New York Times published an article regarding a recent recommendation made by British experts advising that doctors stop implanting metal-on-metal hip replacements in patients.

Army Studies Workout Supplements After Deaths

On February 2, 2012, the New York Times published an article concerning the deaths of two U.S. Army soldiers who were taking dietary supplements containing the ingredient dimethylamylamine (DMAA).

Democrats Want to Let FDA Block Devices Tied to Recalls

On February 2, 2012, Bloomberg Businessweek published an article regarding a recent bill presented by Democratic congressmen that proposes allowing the U.S. Food and Drug Administration (F.D.A.) to block a medical device if it is based on a past product that has been recalled or that has shown a safety issue.